Testosterone Compound (Sustanon) – Genesis | 10ml | 250 mg/ml is an engineered multi-ester blend designed to achieve sustained physiological release alongside rapid initial serum availability. Manufactured by the renowned pharmaceutical laboratory Genesis, this formulation contains four synergistic testosterone esters: Propionate (30 mg), Phenylpropionate (60 mg), Isocaproate (60 mg), and Decanoate (100 mg). This molecular arrangement optimizes bioavailability, eliminating the sharp peaks and troughs common to single-ester protocols while maximizing nitrogen retention, structural protein synthesis, and systemic recovery.
As an anabolic-androgenic compound with an endocrine rating of 100:100, it promotes substantial improvements in muscle cross-sectional area, glycogen replenishment, and insulin-like growth factor 1 (IGF-1) output. By utilizing our lab-tested Sustanon solutions, athletes ensure sustained and stable hormone concentrations, minimizing post-injection crashes and sustaining constant tissue remodeling.
Due to the presence of fast-acting propionate and phenylpropionate esters combined with long-acting decanoate, administration timing should be balanced to maintain steady blood levels:
Testosterone undergoes aromatization into estradiol and 5-alpha reduction into dihydrotestosterone (DHT). To prevent estrogen-related complications such as fluid retention and gynecomastia, maintain an aromatase inhibitor (Arimidex or Aromasin) based on regular biomarker blood testing.
A structured Post-Cycle Therapy (PCT) protocol is mandatory 18 to 21 days after the final injection, allowing the Decanoate ester to clear sufficiently. A clinical PCT cycle combining Clomiphene Citrate (Clomid at 50 mg/day) and Tamoxifen Citrate (Nolvadex at 20 mg/day) for 4 to 6 weeks ensures swift endogenous LH and FSH restoration alongside testicular re-sensitization.
Although the Decanoate ester provides a long overall half-life, the inclusion of short Propionate and Phenylpropionate esters makes twice-weekly injections (e.g., Monday and Thursday) the optimal protocol for minimizing hormonal fluctuations.
Because the long Decanoate ester takes approximately 18 to 21 days to clear to sub-physiological thresholds, full PCT protocols should commence roughly 3 weeks following the final injection.
Yes, aromatase inhibitors such as Anastrozole or Exemestane should be kept on hand and deployed based on blood panels or early symptomatic presentation of water retention, elevated blood pressure, or gynecomastia.
